Risk-Guided Screening for Atrial Fibrillation Using Electronic Health Records
Circulation · 25.08.2026 · 154 (8) · 707-717
DOI: 10.1161/circulationaha.126.079391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 25.08.2026. Verfasst von Ramesh Nadarajah und 42 weiteren Autor:innen. Beteiligte Einrichtung: Leeds Institute of Data Analytics (R.N., A.W., C.R., M.H., T.J., K.R., B.H., K. Kazi, S.B., C.H., C.P.G.), University of Leeds, Leeds, United Kingdom. Hauptthemen laut MEDLINE: Atrial Fibrillation, Electronic Health Records, Mass Screening. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Screening for atrial fibrillation (AF) on the basis of AF risk may be more effective. We aimed to develop, externally validate, and prospectively test a machine learning prediction model using electronic health records (EHRs) to guide AF screening. METHODS: We developed and validated a random forest prediction model for new AF within 6 months, using age, sex, and 10 comorbidities (Future Innovations in Novel Detection of Atrial Fibrillation [FIND-AF] 2.0) in EHRs in the United Kingdom (n=2 081 139), Japan (n=7 795 244), Israel (n=2 166 795), Canada (n=627 919), and China (n=149 145). We conducted a prospective study where participants ≥30 years old without AF and with a CHA 2 DS 2 -VASc score ≥2 in men and ≥3 in women, stratified by FIND-AF 2.0 into high and low risk, undertook 4 ECG recordings per day for 3 weeks using a handheld ECG recorder, with a primary outcome of newly diagnosed AF. We estimated stroke risk associated with nonanticoagulated AF in patients with high FIND-AF 2.0 risk in the FinACAF (Finnish Anticoagulation in Atrial Fibrillation) registry of patients with AF (n=229 565). RESULTS: FIND-AF 2.0 was applicable to all EHRs and showed good to excellent prediction performance (United Kingdom: area under the receiver operating characteristic curve [AUROC], 0.819 [95% CI, 0.809–0.829]; Israel: AUROC, 0.835 [95% CI, 0.828–0.842]; Japan: AUROC, 0.751 [95% CI, 0.745–0.757]; Canada: AUROC, 0.747 [95% CI, 0.741–0.753]; China: AUROC, 0.753 [95% CI, 0.725–0.771]), with AUROC>0.7 in men and women in all cohorts, and improved performance compared with CHA 2 DS 2 -VASc and C 2 HEST (coronary artery disease or chronic obstructive pulmonary disease [1 point each]; hypertension [1 point]; elderly [age ≥75 years, 2 points]; systolic HF [2 points]; thyroid disease [hyperthyroidism, 1 point]). Of 1923 participants from 15 sites in the prospective study (mean age, 70.2 [SD 9.4] years), with a mean of 74.8 (SD, 19.4) ECG recordings, AF was diagnosed in 5 of 902 (0.6%) with low FIND-AF 2.0 risk and 46 of 1021 (4.5%) with high FIND-AF 2.0 risk (odds ratio, 8.46 [95% CI, 3.35–21.40], P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Leeds Institute of Data Analytics (R.N., A.W., C.R., M.H., T.J., K.R., B.H., K. Kazi, S.B., C.H., C.P.G.), University of Leeds, Leeds, United Kingdom.
- Leeds Institute for Cardiovascular and Metabolic Medicine (R.N., A.W., C.R., M.H., T.J., B.H., K. Kazi, S.B., C.H., C.P.G.), University of Leeds, Leeds, United Kingdom.
- Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom (R.N., B.M., C.P.G.).
- Wolfson Institute of Population Health, Queen Mary, University of London, London, United Kingdom (J.W., C.G.).
- Oral Clinical Research Unit, Faculty of Dentistry Oral Craniofacial Sciences, King's College London, London, United Kingdom (J.K.).
- Department of Pharmacoepidemiology, University of Kyoto, Kyoto, Japan (Y.M.N., K. Kawakami).
ORCID-Profile: Ramesh Nadarajah, Mohammad Haris, Tobin Joseph, Ben Hurdus, Chris Hayward, Ben Mercer, Jing Kang, Chenyi Gao, Yoko M Nakao, Abraham Wai, Jiandong Zhou, Gary Tse, Talish Razi Benita, Lior Rokach, Ronen Arbel, Doron Zahger, Dina Labib, Jacqueline Flewitt, James A White, Konsta Teppo, Mika Lehto, Ville Langén, Aleksi K Winstén, K E Juhani Airaksinen, Jari Haukka, Olli Halminen, Jukka Putaala, Juha Hartikainen, Miika Linna, Ben Freedman, Emma Svennberg, A John Camm, Gregory Y H Lip, Chris P Gale
Zitieren
APA
Nadarajah, R., Wu, J., Wahab, A., Reynolds, C., Haris, M., Joseph, T., Raveendra, K., Hurdus, B., Kazi, K., Bennett, S., Hayward, C., Mercer, B., Kang, J., Gao, C., Nakao, Y. M., Kawakami, K., Chang, C., Wai, A., Zhou, J., …, & Gale, C. P. (2026). Risk-Guided Screening for Atrial Fibrillation Using Electronic Health Records. Circulation, 154(8), 707-717. https://doi.org/10.1161/circulationaha.126.079391
Vancouver
Nadarajah R, Wu J, Wahab A, Reynolds C, Haris M, Joseph T, et al. Risk-Guided Screening for Atrial Fibrillation Using Electronic Health Records. Circulation. 2026;154(8):707-717. doi:10.1161/circulationaha.126.079391
BibTeX
@article{Nadarajah2026,
author = {Nadarajah, Ramesh and Wu, Jianhua and Wahab, Ali and Reynolds, Catherine and Haris, Mohammad and Joseph, Tobin and Raveendra, Keerthenan and Hurdus, Ben and Kazi, Khalid and Bennett, Sheena and Hayward, Chris and Mercer, Ben and Kang, Jing and Gao, Chenyi and Nakao, Yoko M and Kawakami, Koji and Chang, Carlin and Wai, Abraham and Zhou, Jiandong and Tse, Gary and Benita, Talish Razi and Rokach, Lior and Arbel, Ronen and Haim, Moti and Zahger, Doron and Labib, Dina and Flewitt, Jacqueline and White, James A and Teppo, Konsta and Lehto, Mika and Langén, Ville and Winstén, Aleksi K and Airaksinen, K E Juhani and Haukka, Jari and Halminen, Olli and Putaala, Jukka and Hartikainen, Juha and Linna, Miika and Freedman, Ben and Svennberg, Emma and Camm, A John and Lip, Gregory Y H and Gale, Chris P},
title = {Risk-Guided Screening for Atrial Fibrillation Using Electronic Health Records},
journal = {Circulation},
year = {2026},
volume = {154},
number = {8},
pages = {707--717},
doi = {10.1161/circulationaha.126.079391}
}
EUVIMED